RBM2-1B [Ligand Id: 8879] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL2024680
  • N-acylsphingosine amidohydrolase 1/Acid ceramidase in Human [ChEMBL: CHEMBL5463] [GtoPdb: 2491] [UniProtKB: Q13510]
There should be some charts here, you may need to enable JavaScript!
  • delta 4-desaturase, sphingolipid 1/Sphingolipid delta(4)-desaturase DES1 in Human [ChEMBL: CHEMBL2021749] [GtoPdb: 2484] [UniProtKB: O15121]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
N-acylsphingosine amidohydrolase 1/Acid ceramidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5463] [GtoPdb: 2491] [UniProtKB: Q13510]
ChEMBL Inhibition of aCDase in Moh.pAS AcCer10X cells using RBM14C12 as substrate after 1 hr by HPLC-FD analysis B 4.11 pIC50 77000 nM IC50 Bioorg Med Chem (2012) 20: 3173-3179 [PMID:22537678]
ChEMBL Inhibition of aCDase using RBM14C12 as substrate after 1 hr by HPLC-FD analysis B 4.11 pIC50 77000 nM IC50 Bioorg Med Chem (2012) 20: 3173-3179 [PMID:22537678]
delta 4-desaturase, sphingolipid 1/Sphingolipid delta(4)-desaturase DES1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2021749] [GtoPdb: 2484] [UniProtKB: O15121]
ChEMBL Inhibition of Des1 in human HCT116 cells assessed as formation of CerC6NBD from dhCerC6NBD after 4 hrs by HPLC-FD analysis B 4.73 pIC50 18800 nM IC50 Bioorg Med Chem (2012) 20: 3173-3179 [PMID:22537678]
GtoPdb Measured in a A549 cellular assay as the formation of CerC6NBD from dihydro CerC6NBD. - 4.74 pIC50 18100 nM IC50 Bioorg Med Chem (2012) 20: 3173-9 [PMID:22537678]
ChEMBL Inhibition of Des1 in human A549 cells assessed as formation of CerC6NBD from dhCerC6NBD after 4 hrs by HPLC-FD analysis B 4.74 pIC50 18100 nM IC50 Bioorg Med Chem (2012) 20: 3173-3179 [PMID:22537678]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]